Literature DB >> 11848687

Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients.

Woan-Ru Lin1, Matthew A Wozniak, Gordon K Wilcock, Ruth F Itzhaki.   

Abstract

We previously found that herpes simplex type 1 virus (HSV1), when present in brain of carriers of the apolipoprotein E type 4 allele is a strong risk factor for Alzheimer's disease. To find if HSV1 or certain other herpesviruses are involved in vascular dementia (VaD), we searched post mortem brain specimens from patients suffering from VaD for the presence of HSV1, cytomegalovirus (CMV), and human herpesvirus type 6 DNA, using polymerase chain reaction. We have found that a very high proportion of the VaD patients, 93% (14/15), but not of age-matched normals, 34% (10/29), harbor CMV DNA (P = 0.0002); the proportions of the patients harboring the other viruses in brain do not differ significantly from those of the normals. Further studies are needed to reveal whether or not the association of CMV with VaD is causal.

Entities:  

Mesh:

Year:  2002        PMID: 11848687     DOI: 10.1006/nbdi.2001.0465

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  29 in total

1.  Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up.

Authors:  Eric T Roberts; Mary N Haan; Jennifer Beam Dowd; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2010-07-21       Impact factor: 4.897

2.  Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort.

Authors:  Vishwajit L Nimgaonkar; Robert H Yolken; Tianxiu Wang; Chung-Chou H Chang; Lora McClain; Eric McDade; Beth E Snitz; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

3.  Carotid atherosclerosis, cytomegalovirus infection, and cognitive decline in the very old: a community-based prospective cohort study.

Authors:  Midori Kawasaki; Yasumichi Arai; Michiyo Takayama; Takumi Hirata; Midori Takayama; Yukiko Abe; Hidehito Niimura; Masaru Mimura; Toru Takebayashi; Nobuyoshi Hirose
Journal:  Age (Dordr)       Date:  2016-02-17

Review 4.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

5.  No Association Found Between Midlife Seropositivity for Infection and Subsequent Cognitive Decline: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Authors:  Kristen M George; Aaron R Folsom; Faye L Norby; Pamela L Lutsey
Journal:  J Geriatr Psychiatry Neurol       Date:  2019-06-16       Impact factor: 2.680

6.  Infectious burden and cognitive function: the Northern Manhattan Study.

Authors:  Mira Katan; Yeseon Park Moon; Myunghee Cho Paik; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  Neurology       Date:  2013-03-26       Impact factor: 9.910

7.  Infectious Burden and Cognitive Decline in the Northern Manhattan Study.

Authors:  Clinton B Wright; Hannah Gardener; Chuanhui Dong; Mitsuhiro Yoshita; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Mitchell S V Elkind
Journal:  J Am Geriatr Soc       Date:  2015-08       Impact factor: 5.562

8.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

9.  Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents.

Authors:  Amanda M Simanek; Caroline Cheng; Robert Yolken; Monica Uddin; Sandro Galea; Allison E Aiello
Journal:  Psychoneuroendocrinology       Date:  2014-08-19       Impact factor: 4.905

10.  Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals.

Authors:  Lisa L Barnes; Ana W Capuano; Alison E Aiello; Arlener D Turner; Robert H Yolken; E Fuller Torrey; David A Bennett
Journal:  J Infect Dis       Date:  2014-08-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.